Recursion Pharmaceuticals Inc has faced significant challenges in its financial performance, highlighted by a sharp decline in revenue growth, which fell to -32.98% in Q3 2025 from +30.14% in Q2 2025.
World Premiere of SPARE PARTS A New Play about Science, Ambition & the Human Soul Written by DAVID J. GLASS and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback